Anxiety-related disorders can have a profound impact on the mental health and quality of life of affected individuals. Understanding the neural circuits and molecular mechanisms that trigger anxiety ...
The global burden of anxiety- and depression-related disorders is on the rise. While multiple drugs have been developed to treat these conditions, current medications have several limitations, ...
PN6047 is a first-in-class small molecule that selectively activates the delta opioid receptor (DOR), avoiding interaction with the mu opioid receptor that is the basis of the addiction and other ...
Researchers from Tokyo University of Science uncover cellular and molecular mechanisms underlying the antidepressant-like effects of the delta opioid receptor agonists, paving the way for its clinical ...
Depression is a condition affecting millions across the globe. However, efficient drugs with minimal adverse effects are scarce. Now, researchers have reported how KNT-127, a delta opioid receptor ...
October 9, 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company PharmNovo has received approval from the Spanish regulatory authorities to initiate a ...
KKCO 11 News on MSN
River Valley Family Health expands Opioid treatment to Delta
D ELTA, Colo. (KKCO) - River Valley Family Health Centers (RVFHC) announced an expansion of their Medication for Opioid Use ...
A delta opioid receptor agonist, KNT-127, exerts anti-stress and anti-depressant activity in mouse model (IMAGE) ...
KREX Grand Junction on MSN
River Valley expands opioid addiction treatment services in Delta
On Monday, River Valley Family Health Centers (RVFHC) announced the expansion of its Medication for Opioid Use Disorder (MOUD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback